Adagene Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADAG Nasdaq 2836 www.adagene.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adagene Inc.

Penny Stocks To Watch In January 2026 - Jan 19th, 2026 5:05 am
3 Promising Penny Stocks With Market Caps Over $30M - Dec 19th, 2025 11:05 am
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug - Dec 17th, 2025 6:43 am
Sector Update: Health Care Stocks Retreat Late Afternoon - Dec 16th, 2025 2:00 pm
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126) - Dec 16th, 2025 5:00 am
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology - Nov 13th, 2025 5:00 am
AC Immune And 2 Other Promising Penny Stocks - Oct 31st, 2025 6:05 am
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer - Oct 31st, 2025 5:00 am
CD47 Inhibitors Drug Market & Clinical Trials Insight 2026, Featuring Adagene, Akeso, ALX Oncology, EpicentRx, ImmuneOncia, ImmuneOnco Biopharma, Phanes Therapeutics, Virtuoso Therapeutics, and More - Oct 1st, 2025 3:13 am
All You Need to Know About Adagene (ADAG) Rating Upgrade to Buy - Sep 30th, 2025 10:00 am
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Sep 25th, 2025 7:40 am
Could Access to SAFEbody Technology Shift Exelixis (EXEL) Pipeline Strategy in Oncology? - Sep 18th, 2025 5:27 am
Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate - Sep 16th, 2025 6:00 am
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? - Sep 8th, 2025 2:59 pm
Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China - Sep 5th, 2025 7:55 am
Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor - Sep 3rd, 2025 7:05 am
Adagene to Participate in Two Investor Conferences in September - Aug 26th, 2025 6:05 am
Is Adagene (ADAG) Outperforming Other Medical Stocks This Year? - Aug 21st, 2025 7:40 am
3 Promising Penny Stocks With Over $90M Market Cap - Aug 21st, 2025 6:09 am
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates - Aug 12th, 2025 2:05 pm